Image-guided versus blind glucocorticoid injection for shoulder pain

Area of Science:

• Musculoskeletal disorders
• Pain management
• Medical imaging

Background:

• Traditional shoulder pain treatment relies on landmark-guided glucocorticoid injections.
• Ultrasound guidance is increasingly used, but its impact on patient outcomes is uncertain.

Purpose of the Study:

• To assess if image-guided glucocorticoid injections improve patient outcomes compared to landmark-guided or intramuscular injections for shoulder pain.

Main Methods:

• Searched Cochrane CENTRAL, MEDLINE, and EMBASE up to June 2011.
• Included randomized controlled trials (RCTs) and quasi-RCTs comparing image-guided to landmark-guided or systemic injections.
• Assessed outcomes including pain, function, range of motion, and adverse events.

Main Results:

• Five studies (290 participants) were included, primarily using ultrasound guidance.
• No significant differences in pain or function were found at 1-2 weeks.
• A significant pain reduction at 6 weeks favoring image guidance was observed in one analysis but was not sustained after sensitivity analysis for bias.

Conclusions:

• Moderate evidence suggests no advantage of ultrasound-guided glucocorticoid injections over landmark-guided or intramuscular injections for shoulder disorders.
• Observed benefits may stem from systemic effects, not solely local accuracy.
• The added cost of ultrasound guidance may not be justified by improved efficacy.